Data Sheet
505(b)(2): 10 Years and Running with 300+ Approvals
In 2003, the FDA unleashed the 505(b)(2) pathway. With a record 47 approvals in 2012, the pathway is helping product developers secure up to 7 years of market exclusivity.
Visit us at AAPS booth 4304 and read our white paper to learn more.